| Literature DB >> 36262469 |
Jason S Kim1, Annunziato Amendola2, Alexej Barg3, Judith Baumhauer4, James W Brodsky5, Daniel M Cushman6, Tyler A Gonzalez7, Dennis Janisse8, Michael J Jurynec9, J Lawrence Marsh10, Carolyn M Sofka11, Thomas O Clanton12, Donald D Anderson10.
Abstract
This first of a 2-part series of articles recounts the key points presented in a collaborative symposium sponsored jointly by the Arthritis Foundation and the American Orthopaedic Foot & Ankle Society with the intent to survey the state of scientific knowledge related to incidence, diagnosis, pathologic mechanisms, and injection treatment options for osteoarthritis (OA) of the foot and ankle. A meeting was held virtually on December 3, 2021. A group of experts were invited to present brief synopses of the current state of knowledge and research in this area. Part 1 overviews areas of epidemiology and pathophysiology, current approaches in imaging, diagnostic and therapeutic injections, and genetics. Opportunities for future research are discussed. The OA scientific community, including funding agencies, academia, industry, and regulatory agencies, must recognize the needs of patients that suffer from arthritis of foot and ankle. The foot and ankle contain a myriad of interrelated joints and tissues that together provide a critical functionality. When this functionality is compromised by OA, significant disability results, yet the foot and ankle are generally understudied by the research community. Level of Evidence: Level V - Review Article/Expert Opinion.Entities:
Keywords: ankle; arthritis; foot; osteoarthritis; subtalar joint
Year: 2022 PMID: 36262469 PMCID: PMC9575439 DOI: 10.1177/24730114221127011
Source DB: PubMed Journal: Foot Ankle Orthop ISSN: 2473-0114